{
  "created_at": "2020-07-12T04:21:51.000Z",
  "updated_at": "2021-01-06T08:25:00.110Z",
  "id": "b3821162-249a-4578-beee-b78459b49500",
  "labels": "current-affairs,2020-07-13",
  "question": "Drugs Controller General of India (DCGI) has approved the psoriasis drug, manufactured by which company, for emergency use in Covid-19?",
  "option1": "Biocon",
  "option2": "Sun Pharma",
  "option3": "Dr Reddy’s",
  "option4": "Cipla",
  "option5": "",
  "answer": "Biocon",
  "explanation": "India’s drug regulator Drugs Controller General of India (DCGI) Dr V G Somani has recently approved ‘Itolizumab’ injection for treating coronavirus patients.\r\nAs per the Union Health Ministry, the drug used to treat psoriasis, will be used for emergency use on Covid-19 patients with medium to severe acute respiratory conditions. The drug has been manufactured by the biopharmaceutical company Biocon, led by Kiran Mazumdar-Shaw."
}